HIGHLIGHTS
- who: Rona R. Ramsay and Massimo Valoti from the Biomedical Sciences Research Complex, University of StAndrews, StAndrews, UK, Department of Biochemical have published the paper: Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration, in the Journal: (JOURNAL)
- what: Lastly in this overview of metabolic aspects of drug design, the action of the CYP isoezymes, important for effectiveness of all drugs in_vivo, on MTDL is described. placebo-controlled trials for H3 receptor antagonists did not find significant effects on cognition (Kubo et_al, 2015). Receptors will not be further mentioned in this article because the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.